Chronic Disease Drugs & Devices

Own the drugmakers and medical-device businesses serving ongoing metabolic, cardiovascular and immune-disease treatment rather than laboratory tools or speculative discovery platforms. The current retreat in technology makes recurring treatment demand an attractive diversification target, while the basket combines established medicine franchises with monitoring and interventional devices. Reimbursement pressure, clinical competition and product execution remain important risks. Launch basket (equal weight): MDT, LLY, JNJ, ABBV, AMGN, ABT, DXCM, BSX, NVO Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.